ArticleBMC cardiovascular disorders2025
Assessment of cardiac dysfunction in COVID-19 patients using layer-specific strain echocardiography in short-axis and long-axis views.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesCardiac dysfunction is commonly observed in COVID-19 patients, but its impact on different myocardial layers-endocardial, mid-myocardial, and epicardial remains insufficiently understood. This study aims to evaluate myocardial dysfunction in COVID-19 patients by assessing both the long-axis and short-axis function of the left ventricle (LV) using two-dimensional myocardial layer-specific strain imaging.
methodsA total of 197 COVID-19 patients were enrolled and categorized into three subgroups: mild, moderate, and severe. Cardiac structural and functional indices, along with biomarker levels, were collected to analyze their correlation with global longitudinal strain (GLS) and global circumferential strain (GCS).
resultsGLS and GCS were reduced in moderate and severe COVID-19 patients, including layer-specific GLS and GCS (both p < 0.05). E/A ratio, left ventricular ejection fraction (LVEF), and myoglobin were identified as independent factors influencing GLS (all p < 0.05). Age, LVEF, cardiac troponin I (cTnI), and myoglobin were independent factors influencing GCS (p < 0.05). Furthermore, B-type Natriuretic Peptide (BNP) and myoglobin were identified as independent predictors of both GLS in the whole wall (GLSww) and endocardial (GLSendo), with β values of -0.22, -0.21 and -0.39, -3.70, respectively (all p < 0.05). GLS, including endocardial, mid-myocardial, and epicardial myocardial layers, demonstrated superior diagnostic performance compared to GCS, with AUC values of 0.81, 0.83, and 0.84 vs. 0.61, 0.57, and 0.55, respectively (all p < 0.001).
conclusionThere are differences in myocardial injury caused by COVID-19 across different layers of the myocardium, both in the longitudinal and circumferential directions, with more pronounced damage observed in the inner myocardium. GLS demonstrated superior diagnostic performance compared to GCS in identifying myocardial dysfunction. Furthermore, myocardial dysfunction was correlated with blood pressure, myocardial structure, and biochemical markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.